Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SOPHiA GENETICS SA (SOPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.3200-0.2700 (-5.88%)
At close: 04:00PM EDT
4.5300 +0.21 (+4.86%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.5900
Open4.6800
Bid1.7600 x 1000
Ask7.0000 x 1000
Day's Range4.2600 - 4.6800
52 Week Range4.2600 - 19.8000
Volume46,880
Avg. Volume70,544
Market Cap275.865M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.2250
Earnings DateSep 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
  • GlobeNewswire

    SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022

    Steady Start to 2022; FY 2022 Constant Currency Revenue Growth Guidance ReaffirmedBOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2022. Recent Highlights Revenue for the first quarter of 2022 was $10.9 million, representing year-over-year revenue growth of 21%Constant currency revenue growth excluding COVID-19-related revenu

  • Simply Wall St.

    Here's What SOPHiA GENETICS SA's (NASDAQ:SOPH) Shareholder Ownership Structure Looks Like

    The big shareholder groups in SOPHiA GENETICS SA ( NASDAQ:SOPH ) have power over the company. Insiders often own a...

  • PR Newswire

    SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors

    SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the nomination of Jean-Michel Cosséry to its Board of Directors. The Board of Directors will propose the appointment of Mr. Cosséry as a member of the Board of Directors and a member of the Compensation Committee to the Annual General Meeting of Shareholders of SOPHiA GENETICS SA, to convene on June 15, 2022.

Advertisement
Advertisement